Re: Geraldine Pignot, Antoine Thiery-Vuillemin, Jochen Walz, et al. Nephrectomy After Complete Response to Immune Checkpoint Inhibitors for Metastatic Renal Cell Carcinoma: A New Surgical Challenge? Eur Urol 2020;77:761-3 The Next Surgical Frontier in Kidney Cancer: Nephrectomy After Immune Checkpoint Inhibition

被引：2
|
作者：
Singla, Nirmish [1 ]
Margulis, Vitaly [1 ]
机构：
[1] Univ Texas Southwestern Med Ctr Dallas, Dept Urol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA
来源：
EUROPEAN UROLOGY | 2020年 / 78卷 / 02期
关键词：
D O I：
10.1016/j.eururo.2020.04.025
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E79 / E80
页数：2
相关论文
共 7 条
  • [1] Reply to Nirmish Singla and Vitaly Margulis's Letter to the Editor re: Geraldine Pignot, Antoine Thiery-Vuillemin, Jochen Walz, et al. Nephrectomy After Complete Response to Immune Checkpoint Inhibitors for Metastatic Renal Cell Carcinoma: A New Surgical Challenge? Eur Urol 2020;77:761-3. The Next Surgical Frontier in Kidney Cancer: Nephrectomy After Immune Checkpoint Inhibition Nephrectomy After Immunotherapy: The Duration of Treatment Exposure is Probably Decisive
    Pignot, Geraldine
    Thiery-Vuillemin, Antoine
    Walz, Jochen
    Bigot, Pierre
    Bensalah, Karim
    Gravis, Gwenaelle
    Barthelemy, Philippe
    [J]. EUROPEAN UROLOGY, 2020, 78 (02) : E81 - E82
  • [2] Nephrectomy After Complete Response to Immune Checkpoint Inhibitors for Metastatic Renal Cell Carcinoma: A New Surgical Challenge?
    Pignot, Geraldine
    Thiery-Vuillemin, Antoine
    Walz, Jochen
    Lang, Herve
    Werle, Pierre
    Balssa, Lac
    Geoffrois, Lionnel
    Leblanc, Louis
    Albiges, Laurence
    di Nunno, Vincenzo
    Bensalah, Karim
    Ladoire, Sylvain
    Gravis, Gwenaelle
    Barthelemy, Philippe
    [J]. EUROPEAN UROLOGY, 2020, 77 (06) : 761 - 763
  • [3] Nephrectomy after complete response to immune checkpoint inhibitors for metastatic renal cell carcinoma (mRCC): A new surgical challenge?
    Pignot, Geraldine
    Thiery-Vuillemin, Antoine
    Walz, Jochen
    Lang, Herve
    Werle, Pierre
    Balssa, Loic
    Geoffrois, Lionnel
    Leblanc, Louis
    Albiges, Laurence
    Di Nunno, Vincenzo
    Bensalah, Karim
    Ladoire, Sylvain
    Gravis, Gwenaelle
    Barthelemy, Philippe
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [4] Nephrectomy after complete response to immune checkpoint inhibitors for Metastatic Renal Cell Carcinoma (mRCC): A surgical challenge allowing favorable oncological outcomes
    Pignot, G.
    Thiery-Vuillemin, A.
    Walz, J.
    Lang, H.
    Balssa, L.
    Geoffrois, L.
    Leblanc, L.
    Albiges, L.
    Bensalah, K.
    Ladoire, S.
    Bigot, P.
    Ingels, A.
    Saldana, C.
    Roubaud, G.
    Piechaud, T.
    Cassuto, O.
    Klifa, D.
    Parier, B.
    Bernhard, J. C.
    Malouf, G.
    Gravis, G.
    Barthelemy, P.
    [J]. EUROPEAN UROLOGY, 2021, 79 : S892 - S893
  • [5] Nephrectomy after response to immune checkpoint inhibitors for metastatic renal cell carcinoma (mRCC): A surgical challenge allowing favorable oncological outcomes.
    Pignot, Geraldine
    Thiery-Vuillemin, Antoine
    Walz, Jochen
    Gaillard, Victor
    Lang, Herve
    Balssa, Loic
    Geoffrois, Lionnel
    Albiges, Laurence
    Bensalah, Karim
    Schlurmann, Friederike
    Ladoire, Sylvain
    Bigot, Pierre
    Ingels, Alexandre
    Roubaud, Guilhem
    Cassuto, Ophelie
    Parier, Bastien
    Bernhard, Jean-Christophe
    Borchiellini, Delphine
    Gravis, Gwenaelle
    Barthelemy, Philippe
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [6] Re: Ziad Bakouny, Talal El Zarif, Shaan Dudani, et al. Upfront Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors or Targeted Therapy: An Observational Study from the International Metastatic Renal Cell Carcinoma Database Consortium. Eur Urol 2023;83:145-51
    Li, Jinze
    Chen, Bo
    Cao, Dehong
    [J]. UROLOGY, 2023, 84 : E75 - E75
  • [7] Re: Laurence Albiges, Tom Powles, Michael Staehler, et al. Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibition Is the New Backbone in First-line Treatment of Metastatic Clear-Cell Renal Cell Carcinoma. Eur Urol 2019;76:151-6 Active Surveillance in Metastatic Renal Cell Cancer: Missing a Chance for Cure?
    de Joode, Karlijn
    van der Veldt, Astrid A. M.
    [J]. EUROPEAN UROLOGY, 2020, 77 (03) : E76 - E77
1